Abstract
Background: Three cases of pulmonary hypertension with severe hypoxaemia were reported in 2002 after prophylactic ibuprofen administration during a randomized controlled trial of prophylactic treatment of patent ductus arteriosus (PDA) in very preterm infants (Gournay et al., Lancet 2002; 359: 1486–88). In a monocentre open study we investigated whether curative treatment with ibuprofen for a haemodynamically significant PDA induced pulmonary hypertension when administered between 24 and 72 h of life in preterm infants under 28 weeks of gestational age (GA).
Methods: 29 preterm newborns below 28 weeks of GA were screened between 24 and 72 h of life for the presence of a haemodynamically relevant PDA, defined as one or more of the following criteria: left atrium/aortic root ratio > 1.4, reduction in diastolic flow in the anterior cerebral artery (resistance index > 0.8) or respiratory step back. Exclusion criteria were: ductus-dependent cardiopathy, right-to-left shunt over the PDA, intra-ventricular haemorrhage grade III or IV or thrombocytopenia < 50.000/nl. Intravenous ibuprofen was started after confirmation of a relevant PDA with 10 mg/kg bodyweight and was continued with two doses of 5 mg/kg in 24 h intervals. Besides determination of a haemodynamically relevant PDA echocardiographic measurements included the following parameters for the evaluation of pulmonary vascular resistance: shunt direction and flow velocity via the ductus and foramen ovale, estimation of the right systolic ventricular pressure (RSVP) in the presence of a tricuspid regurgitation and mean pulmonary artery pressure. In the treated infants these measurements were obtained serially during the ibuprofen course.
Results: Of the 29 screened patients 14 were excluded from the study: 3 patients with severe IVH, 3 with pulmonary hypertension, and 8 due to non-relevant PDA. Among the 15 treated infants 8 showed a tricuspid regurgitation before the first ibuprofen dose with an estimated pulmonary vascular pressure (RSVP median 31 mmHg; range 23–43 mmHg) below systemic systolic pressure (median 41 mmHg; range 32–51 mmHg). The RSVP resolved during ibuprofen administration. In the treatment group PDA-closure rate 24 h after the third ibuprofen dose was 53.3%.
Conclusion: In preterm infants below 28 weeks GA curative treatment with ibuprofen for a haemodynamically significant PDA was not associated with the occurrence of pulmonary hypertension when administered after 24 h of life.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koehne, P., Pees, C. & Obladen, M. 135 Early Ibuprofen Intervention for Preterm Infants Under 28 Gestational Weeks. Pediatr Res 56, 487 (2004). https://doi.org/10.1203/00006450-200409000-00158
Issue date:
DOI: https://doi.org/10.1203/00006450-200409000-00158
